Keyphrases
Atrial Fibrillation
100%
Cancer Patients
100%
In Cancer
100%
Anticoagulation
100%
Thrombocytopenia
100%
Arterial Thromboembolism
30%
Hazard Ratio
23%
Major Bleeding
15%
Platelets
15%
Cumulative Incidence
15%
Retrospective Cohort Study
7%
Patient Characteristics
7%
Ischemic Stroke
7%
Cox Proportional Hazards Model
7%
Low Dose Rate
7%
Bleeding Risk
7%
Bleeding
7%
Anticoagulation Management
7%
Bleeding Rate
7%
Competing Risks
7%
Emboli
7%
Transient Ischemic Attack
7%
Active Cancer
7%
Cancer Grade
7%
CHA2DS2-VASc Score
7%
Atrial Fibrillation or Flutter
7%
Grey Model
7%
Fine Model
7%
Thrombosis Risk
7%
Chemotherapy-induced Thrombocytopenia
7%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Thrombocytopenia
100%
Atrial Fibrillation
100%
Arterial Thromboembolism
80%
Bleeding
60%
Cohort Study
20%
Brain Ischemia
20%
Chemotherapy
20%
Thrombosis
20%
Transient Ischemic Attack
20%
Cancer Grading
20%
Heart Atrium Flutter
20%
Embolism
20%
Medicine and Dentistry
Thrombocytopenia
100%
Atrial Fibrillation
100%
Anticoagulation
100%
Arterial Thromboembolism
28%
Hazard Ratio
21%
Platelet
14%
Major Bleeding
14%
Cumulative Incidence
14%
Malignant Neoplasm
7%
Retrospective Cohort Study
7%
Bleeding
7%
Transient Ischemic Attack
7%
Proportional Hazards Model
7%
Patient Characteristics
7%
Brain Ischemia
7%
Thrombosis
7%
Cancer Grading
7%
CHA2DS2-VASc Score
7%
Atrial Flutter
7%
Embolism
7%
Chemotherapy
7%
INIS
patients
100%
cancer
100%
hazards
44%
risks
33%
management
22%
ischemia
22%
data
11%
thrombosis
11%
death
11%
chemotherapy
11%
adults
11%
emboli
11%